Clinical Trial Update: Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ondansetron orodispersible film to prevent radiotherapy-induced nausea and vomiting in pediatric cancer patients. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Radiotherapy-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron Orodispersible Film (ondansetron)

Snippet

Sponsor: Chongqing University Cancer Hospital | Conditions: Radiotherapy-induced Nausea and Vomiting (RINV), Pediatric Cancer | Phase 4 | Status: RECRUITING